TY - JOUR
T1 - Pediatric Head and Neck Rhabdomyosarcoma
AU - Macarthur, Carol J.
AU - Mcgill, Trevor J.I.
AU - Healy, Gerald B.
PY - 1992/2
Y1 - 1992/2
N2 - Rhabdomyosarcoma (RMS), the most common malignant soft-tissue tumor in the pediatric population, occurs most often in the head and neck region. Major advancements in the management of these aggressive tumors have been achieved in the last 20 years on three fronts: chemotherapy, radiation therapy, and surgery. Surgery, with the advent of skull-base, craniofacial, and free-tissue-transfer reconstructive techniques, has once again become part of the primary management of these tumors. Prior to 1960, RMS was uniformly fatal; now, with the introduction of multimodality treatment regimens, two thirds of patients can expect long-term survival.
AB - Rhabdomyosarcoma (RMS), the most common malignant soft-tissue tumor in the pediatric population, occurs most often in the head and neck region. Major advancements in the management of these aggressive tumors have been achieved in the last 20 years on three fronts: chemotherapy, radiation therapy, and surgery. Surgery, with the advent of skull-base, craniofacial, and free-tissue-transfer reconstructive techniques, has once again become part of the primary management of these tumors. Prior to 1960, RMS was uniformly fatal; now, with the introduction of multimodality treatment regimens, two thirds of patients can expect long-term survival.
UR - http://www.scopus.com/inward/record.url?scp=0026684694&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026684694&partnerID=8YFLogxK
U2 - 10.1177/000992289203100201
DO - 10.1177/000992289203100201
M3 - Article
C2 - 1544277
AN - SCOPUS:0026684694
VL - 31
SP - 66
EP - 70
JO - Clinical Pediatrics
JF - Clinical Pediatrics
SN - 0009-9228
IS - 2
ER -